SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (61225)6/2/1999 10:23:00 AM
From: Knighty Tin  Read Replies (2) | Respond to of 132070
 
Rick, A stock I like that is mostly generic doper, partially biotech, is called Duramed. I just bought a third. They are making a generic version of Estrogen which hits the markets the end of this month. They have other "women's" drugs in the pipeline, some generic copies and a couple of biotech possibles. If these guys can dent the brand names in this market, they will be golden. They do have revenues, but research and marketing gearing up has made for losses so far. This is the first biggie about to launch. Symbol DRMD.



To: scaram(o)uche who wrote (61225)6/2/1999 1:55:00 PM
From: Peter Singleton  Respond to of 132070
 
Rick,

You sure are doing yeoman work keeping the focus on these companies. One of these days folks are going to appreciate the work you're doing to keep the information flow that a healthy capital market requires. Really great work. Nicely done.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News